Publication | Open Access
A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases
69
Citations
29
References
2015
Year
For selected patients with liver metastases, single-fraction SABR at doses of 35 and 40 Gy is tolerable and shows promising signs of efficacy at intermediate follow-up.
| Year | Citations | |
|---|---|---|
Page 1
Page 1